BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Biolato M, Paratore M, Di Gialleonardo L, Marrone G, Grieco A. Direct oral anticoagulant administration in cirrhotic patients with portal vein thrombosis: What is the evidence? World J Hepatol 2022; 14(4): 682-695 [PMID: 35646264 DOI: 10.4254/wjh.v14.i4.682]
URL: https://www.wjgnet.com/1948-9366/full/v14/i4/682.htm
Number Citing Articles
Jing Qian, Shun‐zhong Gu, Yong‐jin Yan. Determination of rivaroxaban in rat plasma by ultra‐high‐performance liquid chromatography–Q‐Orbitrap high‐resolution mass spectrometry and its application to a pharmacokinetic studyBiomedical Chromatography 2022; 36(12) doi: 10.1002/bmc.5491
Nicoletta Riva, Walter Ageno. How to manage splanchnic vein thrombosis in patients with liver diseaseHematology 2023; 2023(1): 281 doi: 10.1182/hematology.2023000481
Aitor Odriozola, Ángela Puente, Antonio Cuadrado, Coral Rivas, Ángela Anton, Francisco José González, Raúl Pellón, Emilio Fábrega, Javier Crespo, José Ignacio Fortea. Portal Vein Thrombosis in the Setting of Cirrhosis: A Comprehensive ReviewJournal of Clinical Medicine 2022; 11(21): 6435 doi: 10.3390/jcm11216435
Giovanni Monaco, Luca Bucherini, Bernardo Stefanini, Fabio Piscaglia, Francesco Giuseppe Foschi, Luca Ielasi. Direct oral anticoagulants for the treatment of splanchnic vein thrombosis: A state of artWorld Journal of Gastroenterology 2023; 29(33): 4962-4974 doi: 10.3748/wjg.v29.i33.4962
Xia Ren, Yuan Huang, LiPing Ying, JinBo Wang. Risk factors of venous thromboembolism for liver tumors: a systematic review and meta-analysisHPB 2024; 26(1): 1 doi: 10.1016/j.hpb.2023.09.008